Fabrinet (FN) — Analysis Summary
Fabrinet (FN) has a market cap of $16.36B with year-over-year revenue growth of +35.7%. Net margin stands at 10.2%. The stock trades at a P/E ratio of 34.6.
Key Takeaways
- Revenue changed +35.7% year-over-year
- Net margin of 10.2%
- P/E ratio of 34.6
Compared to other companies in the TELEPHONE & TELEGRAPH APPARATUS sector, FN posted revenue growth of +35.7% and trades at a P/E of 34.6.
Fabrinet (FN)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.
Sector
TELEPHONE & TELEGRAPH APPARATUS
Employees
21,521
Headquarters
GRAND CAYMAN
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.